<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00865046</url>
  </required_header>
  <id_info>
    <org_study_id>A6614-R</org_study_id>
    <nct_id>NCT00865046</nct_id>
  </id_info>
  <brief_title>Periosteal Stimulation for Knee Osteoarthritis</brief_title>
  <acronym>PST</acronym>
  <official_title>Efficacy of Periosteal Stimulation and Boosters for Advanced Knee OA Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      185 veterans with chronic knee pain and advanced knee osteoarthritis will be recruited to
      participate in this study designed to test the effectiveness of a special type of electrical
      acupuncture called periosteal stimulation (PST). Participants will be divided into three
      groups. They will receive PST or a control condition once a week for 10 weeks. Two-thirds of
      the participants will receive booster sessions periodically over the course of the next 6
      months. Everyone will be called monthly during the 6 month period and then will be asked to
      return for an evaluation on site at the end of this period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We have performed a promising initial trial of periosteal stimulation (PST, that is,
      electrical stimulation of 4 acupuncture needles around the knee that touch periosteum) as an
      analgesic for older veterans with advanced knee osteoarthritis (OA) and daily pain. The
      primary aim of the proposed trial is to optimize and sustain the efficacy of PST for reducing
      pain in veterans with advanced knee OA and unrelieved pain by combining it with booster PST.
      Our secondary aims are to 1) improve physical performance in these individuals, and 2)
      ascertain the physical and psychological predictors of response to PST. In a randomized
      controlled clinical trial, 180 veterans (age 50 and older) with persistent knee pain who have
      x-ray evidence of advanced OA will be assigned to one of three intervention groups: 1)
      control PST once a week for 10 weeks (i.e., needle placement with brief stimulation of
      non-periosteal needles), 2) PST once a week for 10 weeks followed by tapering PST boosters
      over 6 months, or 3) PST once a week for 10 weeks followed by tapering control-PST boosters
      over 6 months. Prior to initiating the intervention, immediately after the last session, and
      6 months later, the following parameters will be assessed: 1) pain severity (WOMAC), 3)
      physical performance (gait velocity, stair climb, repetitive chair rise, timed up and go),
      and 4) psychological function (mood, coping, self-efficacy). Monthly telephone calls will
      assess pain, interim illness and physical activity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain (WOMAC)</measure>
    <time_frame>9 months following baseline</time_frame>
    <description>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:
Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">190</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>PST + PST boosters</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PST once a week for 10 weeks, then tapering over 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PST + control-PST boosters</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PST once a week for 10 weeks, then control-PST tapering over 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control-PST</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>control-PST for 10 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Periosteal stimulation</intervention_name>
    <description>Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.</description>
    <arm_group_label>PST + PST boosters</arm_group_label>
    <arm_group_label>PST + control-PST boosters</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control-Periosteal Stimulation</intervention_name>
    <description>Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
    <arm_group_label>PST + control-PST boosters</arm_group_label>
    <arm_group_label>Control-PST</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking,

          -  Knee pain on most days of the past 3 months that is more severe than pain in other
             parts of the lower body,

          -  Advanced knee OA by x-ray,

          -  age 50-89

        Exclusion Criteria:

          -  Non-ambulatory or severely impaired mobility (i.e., require the use of a walker),

          -  Folstein MMSE &lt; 24,

          -  Severe uncorrected visual or hearing impairment,

          -  Knee pain due to factors other than OA,

          -  Large knee effusion,

          -  History of corticosteroid or hyaluronic acid injection in the affected knee(s) during
             the preceding 3 months,

          -  Acute or terminal illness,

          -  Immune suppression,

          -  Anticoagulation therapy,

          -  Pacemaker,

          -  Prior PST treatment

          -  Active participation in other studies currently

          -  Age &gt;89
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Debra K. Weiner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Geriatric Research, Education, and Clinical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geriatric Research, Education, and Clinical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Weiner DK, Moore CG, Morone NE, Lee ES, Kent Kwoh C. Efficacy of periosteal stimulation for chronic pain associated with advanced knee osteoarthritis: a randomized, controlled clinical trial. Clin Ther. 2013 Nov;35(11):1703-20.e5. doi: 10.1016/j.clinthera.2013.09.025. Epub 2013 Nov 1.</citation>
    <PMID>24184053</PMID>
  </results_reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2009</study_first_submitted>
  <study_first_submitted_qc>March 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2009</study_first_posted>
  <results_first_submitted>December 10, 2014</results_first_submitted>
  <results_first_submitted_qc>January 22, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 26, 2015</results_first_posted>
  <last_update_submitted>January 22, 2015</last_update_submitted>
  <last_update_submitted_qc>January 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1</title>
          <description>PST once a week for 10 weeks, then tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2</title>
          <description>PST once a week for 10 weeks, then control-PST tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
        </group>
        <group group_id="P3">
          <title>Arm 3</title>
          <description>control-PST for 10 weeks
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="64"/>
                <participants group_id="P3" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="59"/>
                <participants group_id="P3" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Community dwelling adults with advanced knee osteoarthritis and chronic pain</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>PST once a week for 10 weeks, then tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2</title>
          <description>PST once a week for 10 weeks, then control-PST tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
        </group>
        <group group_id="B3">
          <title>Arm 3</title>
          <description>control-PST for 10 weeks
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="63"/>
            <count group_id="B2" value="64"/>
            <count group_id="B3" value="63"/>
            <count group_id="B4" value="190"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.1" spread="8.9"/>
                    <measurement group_id="B2" value="65.8" spread="8.7"/>
                    <measurement group_id="B3" value="66.8" spread="10.4"/>
                    <measurement group_id="B4" value="66.5" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="63"/>
                    <measurement group_id="B4" value="188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="63"/>
                    <measurement group_id="B4" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>WOMAC</title>
          <description>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:
Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.0" spread="3.2"/>
                    <measurement group_id="B2" value="9.9" spread="4.0"/>
                    <measurement group_id="B3" value="10.6" spread="3.6"/>
                    <measurement group_id="B4" value="9.8" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Short Physical Performance Battery</title>
          <description>The SPPB measures performance on 3 items:
Repeated chair stands (number of stands and time to complete as well as a 0-4 ordinal scale))
Balance testing - semitandem stand, side-by-side stand, and tandem stand; each scored as 2 (held for 10 sec), 1 (held for less than 10 sec), 0 (not attempted) as well as a 0-4 ordinal scale for overall balance performance
8 foot walk - 0-4 scale according to velocity Summary ordinal score: 0 (worst performance) to 12 (best performance)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.1" spread="1.8"/>
                    <measurement group_id="B2" value="6.1" spread="1.9"/>
                    <measurement group_id="B3" value="6.2" spread="1.5"/>
                    <measurement group_id="B4" value="6.1" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Timed stair climb</title>
          <description>Participants were timed as they ascended and descended 5 steps.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.5" spread="4.7"/>
                    <measurement group_id="B2" value="14.5" spread="7.8"/>
                    <measurement group_id="B3" value="13.9" spread="7.3"/>
                    <measurement group_id="B4" value="13.6" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Timed Up and Go</title>
          <description>The Timed Up and Go (TUG) measures mobility and falls risk. The participant sits in a chair and is timed as (s)he stands up from the chair, walks 3 meters, turns around, walks back to the chair and sits down. The result is expressed in seconds. An older adult who takes at least 12 seconds to complete the TUG is at high risk for falling.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.3" spread="3.4"/>
                    <measurement group_id="B2" value="13.1" spread="3.8"/>
                    <measurement group_id="B3" value="13.9" spread="6.9"/>
                    <measurement group_id="B4" value="13.1" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>CES-D</title>
          <description>The Center for Epidemiological Studies-Depression (CES-D) scale is a measure of depressive symptoms. It is a 20 item. Each item is scored from 0 (rarely or none of the time) to 3 (most or all of the time). Scores range from 0 to 60, with high scores indicating greater depressive symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.7" spread="10.3"/>
                    <measurement group_id="B2" value="14.7" spread="11.2"/>
                    <measurement group_id="B3" value="12.3" spread="9.6"/>
                    <measurement group_id="B4" value="12.9" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cognitive Strategies Questionnaire, catastrophizing scale</title>
          <description>The catastrophizing scale of the Cognitive Strategies Questionnaire consists of 6 items, each scored from 0 (never state that) to 6 (always state that). The scoring range on the instrument is 0 (best pain coping) to 36 (worst pain coping).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.9" spread="7.8"/>
                    <measurement group_id="B2" value="12.1" spread="9.7"/>
                    <measurement group_id="B3" value="8.8" spread="9.2"/>
                    <measurement group_id="B4" value="9.6" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.6" spread="6.5"/>
                    <measurement group_id="B2" value="33.1" spread="6.2"/>
                    <measurement group_id="B3" value="32.5" spread="6.9"/>
                    <measurement group_id="B4" value="32.4" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean number of pain medications</title>
          <description>Mean number of pain medications per day</description>
          <units>medication</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.1" spread="1.0"/>
                    <measurement group_id="B2" value="1.2" spread="0.9"/>
                    <measurement group_id="B3" value="1.0" spread="0.9"/>
                    <measurement group_id="B4" value="1.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean number of opioids</title>
          <description>Mean number of opioids per day</description>
          <units>opioids</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.1" spread="0.3"/>
                    <measurement group_id="B2" value="0.3" spread="0.6"/>
                    <measurement group_id="B3" value="0.2" spread="0.4"/>
                    <measurement group_id="B4" value="0.2" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of knee pain</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.7" spread="6.4"/>
                    <measurement group_id="B2" value="6.2" spread="6.8"/>
                    <measurement group_id="B3" value="7.2" spread="8.3"/>
                    <measurement group_id="B4" value="6.4" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arthritis Self-Efficacy score, pain</title>
          <description>This is the pain subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the pain subscale is 10 to 100.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.3" spread="21.6"/>
                    <measurement group_id="B2" value="59.5" spread="22.6"/>
                    <measurement group_id="B3" value="63.9" spread="21.7"/>
                    <measurement group_id="B4" value="62.6" spread="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arthritis Self-Efficacy score, function</title>
          <description>This is the physical function subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the physical function subscale is 10 to 100.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77.5" spread="17.0"/>
                    <measurement group_id="B2" value="76.3" spread="16.9"/>
                    <measurement group_id="B3" value="76.1" spread="16.4"/>
                    <measurement group_id="B4" value="76.6" spread="16.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arthritis Self-Efficacy score, other symptoms</title>
          <description>This is the other symptoms subscale of The Arthritis Self-Efficacy Scale (ASES). The ASES consists of 20 questions divided into three subscales: physical function (9 questions), other symptoms (6 questions) and pain (5 questions). Participants are asked about their level of certainty that they can perform each task. Each question is scored from 10 = very uncertain to 100 = very certain. Each subscale is scored separately by taking the mean score of the items. Higher scores indicate higher self-efficacy. The range for the other symptoms subscale is 10 to 100.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.5" spread="21.1"/>
                    <measurement group_id="B2" value="65.9" spread="20.3"/>
                    <measurement group_id="B3" value="68.6" spread="20.9"/>
                    <measurement group_id="B4" value="68.3" spread="20.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain (WOMAC)</title>
        <description>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:
Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)</description>
        <time_frame>9 months following baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>PST once a week for 10 weeks, then tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>PST once a week for 10 weeks, then control-PST tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3</title>
            <description>control-PST for 10 weeks
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain (WOMAC)</title>
          <description>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales:
Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="3.5"/>
                    <measurement group_id="O2" value="6.6" spread="3.6"/>
                    <measurement group_id="O3" value="7.9" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>PST once a week for 10 weeks, then tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2</title>
          <description>PST once a week for 10 weeks, then control-PST tapering over 6 months
Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
        </group>
        <group group_id="E3">
          <title>Arm 3</title>
          <description>control-PST for 10 weeks
Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bowel obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>The participant completed participation in the trial. This participant was scheduled to undergo a one year follow-up questionnaire in 6-11 and died 3-11-11.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>sweating</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
              <event>
                <sub_title>Lightheaded</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bruising</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Debra K. Weiner</name_or_title>
      <organization>VA Pittsburgh Healthcare System</organization>
      <phone>412-360-2920</phone>
      <email>debra.weiner@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

